On a disclosed basis, sales fell from KRW 438.2 billion in 2022 to KRW 421.4 billion in 2023, then rose to KRW 435.8 billion in 2024 and KRW 441.1 billion in 2025, two straight years of growth.
Operating profit over the same period went from KRW 77 billion to KRW 67.2 billion, KRW 59.9 billion and KRW 43.6 billion, falling for three consecutive years from 2023 through 2025, with 2025 the smallest year of the four.
The operating margin narrowed from 17.6% in 2022 to 16.0% in 2023, 13.8% in 2024 and 9.9% in 2025, so margins fell even as sales grew. Household chemical sales reached KRW 198.0 billion in 2025 on stronger surfactant exports, but press coverage pointed to cost and expense pressure as the cause of weaker profitability.
R&D spending rose 13.8% to KRW 17.3 billion, which was also cited as a drag on operating profit. Net income attributable to controlling shareholders went from KRW 72.2 billion to KRW 61 billion, KRW 50.5 billion and KRW 43.5 billion, falling for three straight years through 2025, when it was the lowest.
Net income including non-controlling interests was disclosed at the same values in each year. At the end of 2025, total equity was KRW 416.4 billion, all attributable to controlling shareholders, total liabilities were KRW 76.5 billion, and the debt ratio was 18.4%.
Operating cash flow rose from KRW 70.8 billion in 2022 to KRW 97.6 billion in 2023, then fell to KRW 68.6 billion in 2025. On a quarterly basis, sales bottomed at KRW 108.6 billion in the fourth quarter of 2025, then rose for three consecutive quarters through the third quarter of 2026.
Second-quarter 2026 sales were KRW 130.1 billion and operating profit was KRW 20.3 billion, up 106.6% from the prior quarter. Third-quarter sales of KRW 130.2 billion were roughly flat on the quarter, and operating profit of KRW 14.5 billion fell 28.6% from the prior quarter but rose 34.8% from a year earlier.
Over the same third quarter, net income attributable to controlling shareholders of KRW 8.98 billion fell 13.3% from a year earlier, so operating profit and attributable net income moved in opposite directions.
Attributable net income for the last four quarters, from the fourth quarter of 2025 through the third quarter of 2026, totaled KRW 51.4 billion.